Global Needle-free Drug Injectors Market Growth 2026-2032
The global Needle-free Drug Injectors market size is predicted to grow from US$ 240 million in 2025 to US$ 340 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.
Needle-free drug injectors are advanced drug delivery technologies that dispense with the use of traditional syringes and needles in favor of the rapid delivery of drugs to subcutaneous or muscular tissues by means of high-speed liquid streams or other means that penetrate directly into the skin. These systems typically employ the high-pressure injection principle, which utilizes a compressed gas or spring-loaded device to generate sufficient pressure to allow the liquid drug to penetrate the skin barrier and enter the body in the form of an extremely fine, high-speed stream. Needle-free drug injectors are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
United States market for Needle-free Drug Injectors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Needle-free Drug Injectors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Needle-free Drug Injectors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Needle-free Drug Injectors players cover Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Needle-free Drug Injectors Industry Forecast? looks at past sales and reviews total world Needle-free Drug Injectors sales in 2025, providing a comprehensive analysis by region and market sector of projected Needle-free Drug Injectors sales for 2026 through 2032. With Needle-free Drug Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Needle-free Drug Injectors industry.
This Insight Report provides a comprehensive analysis of the global Needle-free Drug Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Needle-free Drug Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Needle-free Drug Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Needle-free Drug Injectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Needle-free Drug Injectors.
This report presents a comprehensive overview, market shares, and growth opportunities of Needle-free Drug Injectors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Needle-free Drug Injectors market?
What factors are driving Needle-free Drug Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Needle-free Drug Injectors market opportunities vary by end market size?
How does Needle-free Drug Injectors break out by Type, by Application?
Needle-free drug injectors are advanced drug delivery technologies that dispense with the use of traditional syringes and needles in favor of the rapid delivery of drugs to subcutaneous or muscular tissues by means of high-speed liquid streams or other means that penetrate directly into the skin. These systems typically employ the high-pressure injection principle, which utilizes a compressed gas or spring-loaded device to generate sufficient pressure to allow the liquid drug to penetrate the skin barrier and enter the body in the form of an extremely fine, high-speed stream. Needle-free drug injectors are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
United States market for Needle-free Drug Injectors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Needle-free Drug Injectors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Needle-free Drug Injectors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Needle-free Drug Injectors players cover Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Needle-free Drug Injectors Industry Forecast? looks at past sales and reviews total world Needle-free Drug Injectors sales in 2025, providing a comprehensive analysis by region and market sector of projected Needle-free Drug Injectors sales for 2026 through 2032. With Needle-free Drug Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Needle-free Drug Injectors industry.
This Insight Report provides a comprehensive analysis of the global Needle-free Drug Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Needle-free Drug Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Needle-free Drug Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Needle-free Drug Injectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Needle-free Drug Injectors.
This report presents a comprehensive overview, market shares, and growth opportunities of Needle-free Drug Injectors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Powder Injections
- Liquid Injections
- Depot or Projectile Injection
- Vaccine Delivery
- Insulin Delivery
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Halozyme (Antares Pharma)
- Inovio Pharmaceuticals
- Endo International
- Injex Pharma GmbH
- National Medical Products (J-Tip)
- Recipharm
- InsuJet
- Miracle Medical
- Medical International Technology (MIT)
- Akra Dermojet
- PharmaJet
- Portal Instruments
- Crossject
- Mika Medical
- Ferring Pharmaceuticals
- IntegriMedical
- Helcomin
- Nugen Medical
- Lepu Medical
- Beijing Quinovare
- Qingdao Zhonghui Health Industrial Group
What is the 10-year outlook for the global Needle-free Drug Injectors market?
What factors are driving Needle-free Drug Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Needle-free Drug Injectors market opportunities vary by end market size?
How does Needle-free Drug Injectors break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle-free Drug Injectors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Needle-free Drug Injectors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Needle-free Drug Injectors by Country/Region, 2021, 2025 & 2032
2.2 Needle-free Drug Injectors Segment by Type
2.2.1 Powder Injections
2.2.2 Liquid Injections
2.2.3 Depot or Projectile Injection
2.2.4 Needle-free Drug Injectors Sales by Type
2.2.4.1 Global Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
2.2.4.2 Global Needle-free Drug Injectors Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Needle-free Drug Injectors Sale Price by Type (2021-2026)
2.3 Needle-free Drug Injectors Segment by Application
2.3.1 Vaccine Delivery
2.3.2 Insulin Delivery
2.3.3 Others
2.3.4 Needle-free Drug Injectors Sales by Application
2.3.4.1 Global Needle-free Drug Injectors Sale Market Share by Application (2021-2026)
2.3.4.2 Global Needle-free Drug Injectors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Needle-free Drug Injectors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Needle-free Drug Injectors Breakdown Data by Company
3.1.1 Global Needle-free Drug Injectors Annual Sales by Company (2021-2026)
3.1.2 Global Needle-free Drug Injectors Sales Market Share by Company (2021-2026)
3.2 Global Needle-free Drug Injectors Annual Revenue by Company (2021-2026)
3.2.1 Global Needle-free Drug Injectors Revenue by Company (2021-2026)
3.2.2 Global Needle-free Drug Injectors Revenue Market Share by Company (2021-2026)
3.3 Global Needle-free Drug Injectors Sale Price by Company
3.4 Key Manufacturers Needle-free Drug Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle-free Drug Injectors Product Location Distribution
3.4.2 Players Needle-free Drug Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEEDLE-FREE DRUG INJECTORS BY GEOGRAPHIC REGION
4.1 World Historic Needle-free Drug Injectors Market Size by Geographic Region (2021-2026)
4.1.1 Global Needle-free Drug Injectors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Needle-free Drug Injectors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Needle-free Drug Injectors Market Size by Country/Region (2021-2026)
4.2.1 Global Needle-free Drug Injectors Annual Sales by Country/Region (2021-2026)
4.2.2 Global Needle-free Drug Injectors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Needle-free Drug Injectors Sales Growth
4.4 APAC Needle-free Drug Injectors Sales Growth
4.5 Europe Needle-free Drug Injectors Sales Growth
4.6 Middle East & Africa Needle-free Drug Injectors Sales Growth
5 AMERICAS
5.1 Americas Needle-free Drug Injectors Sales by Country
5.1.1 Americas Needle-free Drug Injectors Sales by Country (2021-2026)
5.1.2 Americas Needle-free Drug Injectors Revenue by Country (2021-2026)
5.2 Americas Needle-free Drug Injectors Sales by Type (2021-2026)
5.3 Americas Needle-free Drug Injectors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle-free Drug Injectors Sales by Region
6.1.1 APAC Needle-free Drug Injectors Sales by Region (2021-2026)
6.1.2 APAC Needle-free Drug Injectors Revenue by Region (2021-2026)
6.2 APAC Needle-free Drug Injectors Sales by Type (2021-2026)
6.3 APAC Needle-free Drug Injectors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Needle-free Drug Injectors by Country
7.1.1 Europe Needle-free Drug Injectors Sales by Country (2021-2026)
7.1.2 Europe Needle-free Drug Injectors Revenue by Country (2021-2026)
7.2 Europe Needle-free Drug Injectors Sales by Type (2021-2026)
7.3 Europe Needle-free Drug Injectors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle-free Drug Injectors by Country
8.1.1 Middle East & Africa Needle-free Drug Injectors Sales by Country (2021-2026)
8.1.2 Middle East & Africa Needle-free Drug Injectors Revenue by Country (2021-2026)
8.2 Middle East & Africa Needle-free Drug Injectors Sales by Type (2021-2026)
8.3 Middle East & Africa Needle-free Drug Injectors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Needle-free Drug Injectors
10.3 Manufacturing Process Analysis of Needle-free Drug Injectors
10.4 Industry Chain Structure of Needle-free Drug Injectors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Needle-free Drug Injectors Distributors
11.3 Needle-free Drug Injectors Customer
12 WORLD FORECAST REVIEW FOR NEEDLE-FREE DRUG INJECTORS BY GEOGRAPHIC REGION
12.1 Global Needle-free Drug Injectors Market Size Forecast by Region
12.1.1 Global Needle-free Drug Injectors Forecast by Region (2027-2032)
12.1.2 Global Needle-free Drug Injectors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Needle-free Drug Injectors Forecast by Type (2027-2032)
12.7 Global Needle-free Drug Injectors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Halozyme (Antares Pharma)
13.1.1 Halozyme (Antares Pharma) Company Information
13.1.2 Halozyme (Antares Pharma) Needle-free Drug Injectors Product Portfolios and Specifications
13.1.3 Halozyme (Antares Pharma) Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Halozyme (Antares Pharma) Main Business Overview
13.1.5 Halozyme (Antares Pharma) Latest Developments
13.2 Inovio Pharmaceuticals
13.2.1 Inovio Pharmaceuticals Company Information
13.2.2 Inovio Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
13.2.3 Inovio Pharmaceuticals Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Inovio Pharmaceuticals Main Business Overview
13.2.5 Inovio Pharmaceuticals Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Needle-free Drug Injectors Product Portfolios and Specifications
13.3.3 Endo International Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 Injex Pharma GmbH
13.4.1 Injex Pharma GmbH Company Information
13.4.2 Injex Pharma GmbH Needle-free Drug Injectors Product Portfolios and Specifications
13.4.3 Injex Pharma GmbH Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Injex Pharma GmbH Main Business Overview
13.4.5 Injex Pharma GmbH Latest Developments
13.5 National Medical Products (J-Tip)
13.5.1 National Medical Products (J-Tip) Company Information
13.5.2 National Medical Products (J-Tip) Needle-free Drug Injectors Product Portfolios and Specifications
13.5.3 National Medical Products (J-Tip) Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 National Medical Products (J-Tip) Main Business Overview
13.5.5 National Medical Products (J-Tip) Latest Developments
13.6 Recipharm
13.6.1 Recipharm Company Information
13.6.2 Recipharm Needle-free Drug Injectors Product Portfolios and Specifications
13.6.3 Recipharm Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Recipharm Main Business Overview
13.6.5 Recipharm Latest Developments
13.7 InsuJet
13.7.1 InsuJet Company Information
13.7.2 InsuJet Needle-free Drug Injectors Product Portfolios and Specifications
13.7.3 InsuJet Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 InsuJet Main Business Overview
13.7.5 InsuJet Latest Developments
13.8 Miracle Medical
13.8.1 Miracle Medical Company Information
13.8.2 Miracle Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.8.3 Miracle Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Miracle Medical Main Business Overview
13.8.5 Miracle Medical Latest Developments
13.9 Medical International Technology (MIT)
13.9.1 Medical International Technology (MIT) Company Information
13.9.2 Medical International Technology (MIT) Needle-free Drug Injectors Product Portfolios and Specifications
13.9.3 Medical International Technology (MIT) Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Medical International Technology (MIT) Main Business Overview
13.9.5 Medical International Technology (MIT) Latest Developments
13.10 Akra Dermojet
13.10.1 Akra Dermojet Company Information
13.10.2 Akra Dermojet Needle-free Drug Injectors Product Portfolios and Specifications
13.10.3 Akra Dermojet Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Akra Dermojet Main Business Overview
13.10.5 Akra Dermojet Latest Developments
13.11 PharmaJet
13.11.1 PharmaJet Company Information
13.11.2 PharmaJet Needle-free Drug Injectors Product Portfolios and Specifications
13.11.3 PharmaJet Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 PharmaJet Main Business Overview
13.11.5 PharmaJet Latest Developments
13.12 Portal Instruments
13.12.1 Portal Instruments Company Information
13.12.2 Portal Instruments Needle-free Drug Injectors Product Portfolios and Specifications
13.12.3 Portal Instruments Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Portal Instruments Main Business Overview
13.12.5 Portal Instruments Latest Developments
13.13 Crossject
13.13.1 Crossject Company Information
13.13.2 Crossject Needle-free Drug Injectors Product Portfolios and Specifications
13.13.3 Crossject Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Crossject Main Business Overview
13.13.5 Crossject Latest Developments
13.14 Mika Medical
13.14.1 Mika Medical Company Information
13.14.2 Mika Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.14.3 Mika Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Mika Medical Main Business Overview
13.14.5 Mika Medical Latest Developments
13.15 Ferring Pharmaceuticals
13.15.1 Ferring Pharmaceuticals Company Information
13.15.2 Ferring Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
13.15.3 Ferring Pharmaceuticals Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Ferring Pharmaceuticals Main Business Overview
13.15.5 Ferring Pharmaceuticals Latest Developments
13.16 IntegriMedical
13.16.1 IntegriMedical Company Information
13.16.2 IntegriMedical Needle-free Drug Injectors Product Portfolios and Specifications
13.16.3 IntegriMedical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 IntegriMedical Main Business Overview
13.16.5 IntegriMedical Latest Developments
13.17 Helcomin
13.17.1 Helcomin Company Information
13.17.2 Helcomin Needle-free Drug Injectors Product Portfolios and Specifications
13.17.3 Helcomin Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Helcomin Main Business Overview
13.17.5 Helcomin Latest Developments
13.18 Nugen Medical
13.18.1 Nugen Medical Company Information
13.18.2 Nugen Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.18.3 Nugen Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Nugen Medical Main Business Overview
13.18.5 Nugen Medical Latest Developments
13.19 Lepu Medical
13.19.1 Lepu Medical Company Information
13.19.2 Lepu Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.19.3 Lepu Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Lepu Medical Main Business Overview
13.19.5 Lepu Medical Latest Developments
13.20 Beijing Quinovare
13.20.1 Beijing Quinovare Company Information
13.20.2 Beijing Quinovare Needle-free Drug Injectors Product Portfolios and Specifications
13.20.3 Beijing Quinovare Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Beijing Quinovare Main Business Overview
13.20.5 Beijing Quinovare Latest Developments
13.21 Qingdao Zhonghui Health Industrial Group
13.21.1 Qingdao Zhonghui Health Industrial Group Company Information
13.21.2 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product Portfolios and Specifications
13.21.3 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Qingdao Zhonghui Health Industrial Group Main Business Overview
13.21.5 Qingdao Zhonghui Health Industrial Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle-free Drug Injectors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Needle-free Drug Injectors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Needle-free Drug Injectors by Country/Region, 2021, 2025 & 2032
2.2 Needle-free Drug Injectors Segment by Type
2.2.1 Powder Injections
2.2.2 Liquid Injections
2.2.3 Depot or Projectile Injection
2.2.4 Needle-free Drug Injectors Sales by Type
2.2.4.1 Global Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
2.2.4.2 Global Needle-free Drug Injectors Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Needle-free Drug Injectors Sale Price by Type (2021-2026)
2.3 Needle-free Drug Injectors Segment by Application
2.3.1 Vaccine Delivery
2.3.2 Insulin Delivery
2.3.3 Others
2.3.4 Needle-free Drug Injectors Sales by Application
2.3.4.1 Global Needle-free Drug Injectors Sale Market Share by Application (2021-2026)
2.3.4.2 Global Needle-free Drug Injectors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Needle-free Drug Injectors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Needle-free Drug Injectors Breakdown Data by Company
3.1.1 Global Needle-free Drug Injectors Annual Sales by Company (2021-2026)
3.1.2 Global Needle-free Drug Injectors Sales Market Share by Company (2021-2026)
3.2 Global Needle-free Drug Injectors Annual Revenue by Company (2021-2026)
3.2.1 Global Needle-free Drug Injectors Revenue by Company (2021-2026)
3.2.2 Global Needle-free Drug Injectors Revenue Market Share by Company (2021-2026)
3.3 Global Needle-free Drug Injectors Sale Price by Company
3.4 Key Manufacturers Needle-free Drug Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle-free Drug Injectors Product Location Distribution
3.4.2 Players Needle-free Drug Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEEDLE-FREE DRUG INJECTORS BY GEOGRAPHIC REGION
4.1 World Historic Needle-free Drug Injectors Market Size by Geographic Region (2021-2026)
4.1.1 Global Needle-free Drug Injectors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Needle-free Drug Injectors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Needle-free Drug Injectors Market Size by Country/Region (2021-2026)
4.2.1 Global Needle-free Drug Injectors Annual Sales by Country/Region (2021-2026)
4.2.2 Global Needle-free Drug Injectors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Needle-free Drug Injectors Sales Growth
4.4 APAC Needle-free Drug Injectors Sales Growth
4.5 Europe Needle-free Drug Injectors Sales Growth
4.6 Middle East & Africa Needle-free Drug Injectors Sales Growth
5 AMERICAS
5.1 Americas Needle-free Drug Injectors Sales by Country
5.1.1 Americas Needle-free Drug Injectors Sales by Country (2021-2026)
5.1.2 Americas Needle-free Drug Injectors Revenue by Country (2021-2026)
5.2 Americas Needle-free Drug Injectors Sales by Type (2021-2026)
5.3 Americas Needle-free Drug Injectors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle-free Drug Injectors Sales by Region
6.1.1 APAC Needle-free Drug Injectors Sales by Region (2021-2026)
6.1.2 APAC Needle-free Drug Injectors Revenue by Region (2021-2026)
6.2 APAC Needle-free Drug Injectors Sales by Type (2021-2026)
6.3 APAC Needle-free Drug Injectors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Needle-free Drug Injectors by Country
7.1.1 Europe Needle-free Drug Injectors Sales by Country (2021-2026)
7.1.2 Europe Needle-free Drug Injectors Revenue by Country (2021-2026)
7.2 Europe Needle-free Drug Injectors Sales by Type (2021-2026)
7.3 Europe Needle-free Drug Injectors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle-free Drug Injectors by Country
8.1.1 Middle East & Africa Needle-free Drug Injectors Sales by Country (2021-2026)
8.1.2 Middle East & Africa Needle-free Drug Injectors Revenue by Country (2021-2026)
8.2 Middle East & Africa Needle-free Drug Injectors Sales by Type (2021-2026)
8.3 Middle East & Africa Needle-free Drug Injectors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Needle-free Drug Injectors
10.3 Manufacturing Process Analysis of Needle-free Drug Injectors
10.4 Industry Chain Structure of Needle-free Drug Injectors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Needle-free Drug Injectors Distributors
11.3 Needle-free Drug Injectors Customer
12 WORLD FORECAST REVIEW FOR NEEDLE-FREE DRUG INJECTORS BY GEOGRAPHIC REGION
12.1 Global Needle-free Drug Injectors Market Size Forecast by Region
12.1.1 Global Needle-free Drug Injectors Forecast by Region (2027-2032)
12.1.2 Global Needle-free Drug Injectors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Needle-free Drug Injectors Forecast by Type (2027-2032)
12.7 Global Needle-free Drug Injectors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Halozyme (Antares Pharma)
13.1.1 Halozyme (Antares Pharma) Company Information
13.1.2 Halozyme (Antares Pharma) Needle-free Drug Injectors Product Portfolios and Specifications
13.1.3 Halozyme (Antares Pharma) Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Halozyme (Antares Pharma) Main Business Overview
13.1.5 Halozyme (Antares Pharma) Latest Developments
13.2 Inovio Pharmaceuticals
13.2.1 Inovio Pharmaceuticals Company Information
13.2.2 Inovio Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
13.2.3 Inovio Pharmaceuticals Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Inovio Pharmaceuticals Main Business Overview
13.2.5 Inovio Pharmaceuticals Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Needle-free Drug Injectors Product Portfolios and Specifications
13.3.3 Endo International Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 Injex Pharma GmbH
13.4.1 Injex Pharma GmbH Company Information
13.4.2 Injex Pharma GmbH Needle-free Drug Injectors Product Portfolios and Specifications
13.4.3 Injex Pharma GmbH Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Injex Pharma GmbH Main Business Overview
13.4.5 Injex Pharma GmbH Latest Developments
13.5 National Medical Products (J-Tip)
13.5.1 National Medical Products (J-Tip) Company Information
13.5.2 National Medical Products (J-Tip) Needle-free Drug Injectors Product Portfolios and Specifications
13.5.3 National Medical Products (J-Tip) Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 National Medical Products (J-Tip) Main Business Overview
13.5.5 National Medical Products (J-Tip) Latest Developments
13.6 Recipharm
13.6.1 Recipharm Company Information
13.6.2 Recipharm Needle-free Drug Injectors Product Portfolios and Specifications
13.6.3 Recipharm Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Recipharm Main Business Overview
13.6.5 Recipharm Latest Developments
13.7 InsuJet
13.7.1 InsuJet Company Information
13.7.2 InsuJet Needle-free Drug Injectors Product Portfolios and Specifications
13.7.3 InsuJet Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 InsuJet Main Business Overview
13.7.5 InsuJet Latest Developments
13.8 Miracle Medical
13.8.1 Miracle Medical Company Information
13.8.2 Miracle Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.8.3 Miracle Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Miracle Medical Main Business Overview
13.8.5 Miracle Medical Latest Developments
13.9 Medical International Technology (MIT)
13.9.1 Medical International Technology (MIT) Company Information
13.9.2 Medical International Technology (MIT) Needle-free Drug Injectors Product Portfolios and Specifications
13.9.3 Medical International Technology (MIT) Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Medical International Technology (MIT) Main Business Overview
13.9.5 Medical International Technology (MIT) Latest Developments
13.10 Akra Dermojet
13.10.1 Akra Dermojet Company Information
13.10.2 Akra Dermojet Needle-free Drug Injectors Product Portfolios and Specifications
13.10.3 Akra Dermojet Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Akra Dermojet Main Business Overview
13.10.5 Akra Dermojet Latest Developments
13.11 PharmaJet
13.11.1 PharmaJet Company Information
13.11.2 PharmaJet Needle-free Drug Injectors Product Portfolios and Specifications
13.11.3 PharmaJet Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 PharmaJet Main Business Overview
13.11.5 PharmaJet Latest Developments
13.12 Portal Instruments
13.12.1 Portal Instruments Company Information
13.12.2 Portal Instruments Needle-free Drug Injectors Product Portfolios and Specifications
13.12.3 Portal Instruments Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Portal Instruments Main Business Overview
13.12.5 Portal Instruments Latest Developments
13.13 Crossject
13.13.1 Crossject Company Information
13.13.2 Crossject Needle-free Drug Injectors Product Portfolios and Specifications
13.13.3 Crossject Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Crossject Main Business Overview
13.13.5 Crossject Latest Developments
13.14 Mika Medical
13.14.1 Mika Medical Company Information
13.14.2 Mika Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.14.3 Mika Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Mika Medical Main Business Overview
13.14.5 Mika Medical Latest Developments
13.15 Ferring Pharmaceuticals
13.15.1 Ferring Pharmaceuticals Company Information
13.15.2 Ferring Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
13.15.3 Ferring Pharmaceuticals Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Ferring Pharmaceuticals Main Business Overview
13.15.5 Ferring Pharmaceuticals Latest Developments
13.16 IntegriMedical
13.16.1 IntegriMedical Company Information
13.16.2 IntegriMedical Needle-free Drug Injectors Product Portfolios and Specifications
13.16.3 IntegriMedical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 IntegriMedical Main Business Overview
13.16.5 IntegriMedical Latest Developments
13.17 Helcomin
13.17.1 Helcomin Company Information
13.17.2 Helcomin Needle-free Drug Injectors Product Portfolios and Specifications
13.17.3 Helcomin Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Helcomin Main Business Overview
13.17.5 Helcomin Latest Developments
13.18 Nugen Medical
13.18.1 Nugen Medical Company Information
13.18.2 Nugen Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.18.3 Nugen Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Nugen Medical Main Business Overview
13.18.5 Nugen Medical Latest Developments
13.19 Lepu Medical
13.19.1 Lepu Medical Company Information
13.19.2 Lepu Medical Needle-free Drug Injectors Product Portfolios and Specifications
13.19.3 Lepu Medical Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Lepu Medical Main Business Overview
13.19.5 Lepu Medical Latest Developments
13.20 Beijing Quinovare
13.20.1 Beijing Quinovare Company Information
13.20.2 Beijing Quinovare Needle-free Drug Injectors Product Portfolios and Specifications
13.20.3 Beijing Quinovare Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Beijing Quinovare Main Business Overview
13.20.5 Beijing Quinovare Latest Developments
13.21 Qingdao Zhonghui Health Industrial Group
13.21.1 Qingdao Zhonghui Health Industrial Group Company Information
13.21.2 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product Portfolios and Specifications
13.21.3 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Qingdao Zhonghui Health Industrial Group Main Business Overview
13.21.5 Qingdao Zhonghui Health Industrial Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Needle-free Drug Injectors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Needle-free Drug Injectors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder Injections
Table 4. Major Players of Liquid Injections
Table 5. Major Players of Depot or Projectile Injection
Table 6. Global Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 7. Global Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Table 8. Global Needle-free Drug Injectors Revenue by Type (2021-2026) & ($ million)
Table 9. Global Needle-free Drug Injectors Revenue Market Share by Type (2021-2026)
Table 10. Global Needle-free Drug Injectors Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Needle-free Drug Injectors Sale by Application (2021-2026) & (K Units)
Table 12. Global Needle-free Drug Injectors Sale Market Share by Application (2021-2026)
Table 13. Global Needle-free Drug Injectors Revenue by Application (2021-2026) & ($ million)
Table 14. Global Needle-free Drug Injectors Revenue Market Share by Application (2021-2026)
Table 15. Global Needle-free Drug Injectors Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Needle-free Drug Injectors Sales by Company (2021-2026) & (K Units)
Table 17. Global Needle-free Drug Injectors Sales Market Share by Company (2021-2026)
Table 18. Global Needle-free Drug Injectors Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Needle-free Drug Injectors Revenue Market Share by Company (2021-2026)
Table 20. Global Needle-free Drug Injectors Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Needle-free Drug Injectors Producing Area Distribution and Sales Area
Table 22. Players Needle-free Drug Injectors Products Offered
Table 23. Needle-free Drug Injectors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Needle-free Drug Injectors Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Needle-free Drug Injectors Sales Market Share Geographic Region (2021-2026)
Table 28. Global Needle-free Drug Injectors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Needle-free Drug Injectors Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Needle-free Drug Injectors Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Needle-free Drug Injectors Sales Market Share by Country/Region (2021-2026)
Table 32. Global Needle-free Drug Injectors Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Needle-free Drug Injectors Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Needle-free Drug Injectors Sales by Country (2021-2026) & (K Units)
Table 35. Americas Needle-free Drug Injectors Sales Market Share by Country (2021-2026)
Table 36. Americas Needle-free Drug Injectors Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 38. Americas Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 39. APAC Needle-free Drug Injectors Sales by Region (2021-2026) & (K Units)
Table 40. APAC Needle-free Drug Injectors Sales Market Share by Region (2021-2026)
Table 41. APAC Needle-free Drug Injectors Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 43. APAC Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 44. Europe Needle-free Drug Injectors Sales by Country (2021-2026) & (K Units)
Table 45. Europe Needle-free Drug Injectors Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 47. Europe Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Needle-free Drug Injectors Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Needle-free Drug Injectors Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Needle-free Drug Injectors
Table 53. Key Market Challenges & Risks of Needle-free Drug Injectors
Table 54. Key Industry Trends of Needle-free Drug Injectors
Table 55. Needle-free Drug Injectors Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Needle-free Drug Injectors Distributors List
Table 58. Needle-free Drug Injectors Customer List
Table 59. Global Needle-free Drug Injectors Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Needle-free Drug Injectors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Needle-free Drug Injectors Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Needle-free Drug Injectors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Needle-free Drug Injectors Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Needle-free Drug Injectors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Needle-free Drug Injectors Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Needle-free Drug Injectors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Needle-free Drug Injectors Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Needle-free Drug Injectors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Needle-free Drug Injectors Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Needle-free Drug Injectors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Needle-free Drug Injectors Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Needle-free Drug Injectors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Halozyme (Antares Pharma) Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 74. Halozyme (Antares Pharma) Needle-free Drug Injectors Product Portfolios and Specifications
Table 75. Halozyme (Antares Pharma) Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Halozyme (Antares Pharma) Main Business
Table 77. Halozyme (Antares Pharma) Latest Developments
Table 78. Inovio Pharmaceuticals Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 79. Inovio Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
Table 80. Inovio Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Inovio Pharmaceuticals Main Business
Table 82. Inovio Pharmaceuticals Latest Developments
Table 83. Endo International Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 84. Endo International Needle-free Drug Injectors Product Portfolios and Specifications
Table 85. Endo International Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Endo International Main Business
Table 87. Endo International Latest Developments
Table 88. Injex Pharma GmbH Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 89. Injex Pharma GmbH Needle-free Drug Injectors Product Portfolios and Specifications
Table 90. Injex Pharma GmbH Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Injex Pharma GmbH Main Business
Table 92. Injex Pharma GmbH Latest Developments
Table 93. National Medical Products (J-Tip) Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 94. National Medical Products (J-Tip) Needle-free Drug Injectors Product Portfolios and Specifications
Table 95. National Medical Products (J-Tip) Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. National Medical Products (J-Tip) Main Business
Table 97. National Medical Products (J-Tip) Latest Developments
Table 98. Recipharm Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 99. Recipharm Needle-free Drug Injectors Product Portfolios and Specifications
Table 100. Recipharm Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Recipharm Main Business
Table 102. Recipharm Latest Developments
Table 103. InsuJet Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 104. InsuJet Needle-free Drug Injectors Product Portfolios and Specifications
Table 105. InsuJet Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. InsuJet Main Business
Table 107. InsuJet Latest Developments
Table 108. Miracle Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 109. Miracle Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 110. Miracle Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Miracle Medical Main Business
Table 112. Miracle Medical Latest Developments
Table 113. Medical International Technology (MIT) Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 114. Medical International Technology (MIT) Needle-free Drug Injectors Product Portfolios and Specifications
Table 115. Medical International Technology (MIT) Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Medical International Technology (MIT) Main Business
Table 117. Medical International Technology (MIT) Latest Developments
Table 118. Akra Dermojet Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 119. Akra Dermojet Needle-free Drug Injectors Product Portfolios and Specifications
Table 120. Akra Dermojet Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Akra Dermojet Main Business
Table 122. Akra Dermojet Latest Developments
Table 123. PharmaJet Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 124. PharmaJet Needle-free Drug Injectors Product Portfolios and Specifications
Table 125. PharmaJet Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. PharmaJet Main Business
Table 127. PharmaJet Latest Developments
Table 128. Portal Instruments Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 129. Portal Instruments Needle-free Drug Injectors Product Portfolios and Specifications
Table 130. Portal Instruments Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Portal Instruments Main Business
Table 132. Portal Instruments Latest Developments
Table 133. Crossject Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 134. Crossject Needle-free Drug Injectors Product Portfolios and Specifications
Table 135. Crossject Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Crossject Main Business
Table 137. Crossject Latest Developments
Table 138. Mika Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 139. Mika Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 140. Mika Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Mika Medical Main Business
Table 142. Mika Medical Latest Developments
Table 143. Ferring Pharmaceuticals Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 144. Ferring Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
Table 145. Ferring Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Ferring Pharmaceuticals Main Business
Table 147. Ferring Pharmaceuticals Latest Developments
Table 148. IntegriMedical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 149. IntegriMedical Needle-free Drug Injectors Product Portfolios and Specifications
Table 150. IntegriMedical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. IntegriMedical Main Business
Table 152. IntegriMedical Latest Developments
Table 153. Helcomin Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 154. Helcomin Needle-free Drug Injectors Product Portfolios and Specifications
Table 155. Helcomin Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Helcomin Main Business
Table 157. Helcomin Latest Developments
Table 158. Nugen Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 159. Nugen Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 160. Nugen Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Nugen Medical Main Business
Table 162. Nugen Medical Latest Developments
Table 163. Lepu Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 164. Lepu Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 165. Lepu Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Lepu Medical Main Business
Table 167. Lepu Medical Latest Developments
Table 168. Beijing Quinovare Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 169. Beijing Quinovare Needle-free Drug Injectors Product Portfolios and Specifications
Table 170. Beijing Quinovare Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Beijing Quinovare Main Business
Table 172. Beijing Quinovare Latest Developments
Table 173. Qingdao Zhonghui Health Industrial Group Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 174. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product Portfolios and Specifications
Table 175. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Qingdao Zhonghui Health Industrial Group Main Business
Table 177. Qingdao Zhonghui Health Industrial Group Latest Developments
Table 1. Needle-free Drug Injectors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Needle-free Drug Injectors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder Injections
Table 4. Major Players of Liquid Injections
Table 5. Major Players of Depot or Projectile Injection
Table 6. Global Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 7. Global Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Table 8. Global Needle-free Drug Injectors Revenue by Type (2021-2026) & ($ million)
Table 9. Global Needle-free Drug Injectors Revenue Market Share by Type (2021-2026)
Table 10. Global Needle-free Drug Injectors Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Needle-free Drug Injectors Sale by Application (2021-2026) & (K Units)
Table 12. Global Needle-free Drug Injectors Sale Market Share by Application (2021-2026)
Table 13. Global Needle-free Drug Injectors Revenue by Application (2021-2026) & ($ million)
Table 14. Global Needle-free Drug Injectors Revenue Market Share by Application (2021-2026)
Table 15. Global Needle-free Drug Injectors Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Needle-free Drug Injectors Sales by Company (2021-2026) & (K Units)
Table 17. Global Needle-free Drug Injectors Sales Market Share by Company (2021-2026)
Table 18. Global Needle-free Drug Injectors Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Needle-free Drug Injectors Revenue Market Share by Company (2021-2026)
Table 20. Global Needle-free Drug Injectors Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Needle-free Drug Injectors Producing Area Distribution and Sales Area
Table 22. Players Needle-free Drug Injectors Products Offered
Table 23. Needle-free Drug Injectors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Needle-free Drug Injectors Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Needle-free Drug Injectors Sales Market Share Geographic Region (2021-2026)
Table 28. Global Needle-free Drug Injectors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Needle-free Drug Injectors Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Needle-free Drug Injectors Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Needle-free Drug Injectors Sales Market Share by Country/Region (2021-2026)
Table 32. Global Needle-free Drug Injectors Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Needle-free Drug Injectors Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Needle-free Drug Injectors Sales by Country (2021-2026) & (K Units)
Table 35. Americas Needle-free Drug Injectors Sales Market Share by Country (2021-2026)
Table 36. Americas Needle-free Drug Injectors Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 38. Americas Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 39. APAC Needle-free Drug Injectors Sales by Region (2021-2026) & (K Units)
Table 40. APAC Needle-free Drug Injectors Sales Market Share by Region (2021-2026)
Table 41. APAC Needle-free Drug Injectors Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 43. APAC Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 44. Europe Needle-free Drug Injectors Sales by Country (2021-2026) & (K Units)
Table 45. Europe Needle-free Drug Injectors Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 47. Europe Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Needle-free Drug Injectors Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Needle-free Drug Injectors Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Needle-free Drug Injectors Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Needle-free Drug Injectors Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Needle-free Drug Injectors
Table 53. Key Market Challenges & Risks of Needle-free Drug Injectors
Table 54. Key Industry Trends of Needle-free Drug Injectors
Table 55. Needle-free Drug Injectors Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Needle-free Drug Injectors Distributors List
Table 58. Needle-free Drug Injectors Customer List
Table 59. Global Needle-free Drug Injectors Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Needle-free Drug Injectors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Needle-free Drug Injectors Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Needle-free Drug Injectors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Needle-free Drug Injectors Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Needle-free Drug Injectors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Needle-free Drug Injectors Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Needle-free Drug Injectors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Needle-free Drug Injectors Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Needle-free Drug Injectors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Needle-free Drug Injectors Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Needle-free Drug Injectors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Needle-free Drug Injectors Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Needle-free Drug Injectors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Halozyme (Antares Pharma) Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 74. Halozyme (Antares Pharma) Needle-free Drug Injectors Product Portfolios and Specifications
Table 75. Halozyme (Antares Pharma) Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Halozyme (Antares Pharma) Main Business
Table 77. Halozyme (Antares Pharma) Latest Developments
Table 78. Inovio Pharmaceuticals Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 79. Inovio Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
Table 80. Inovio Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Inovio Pharmaceuticals Main Business
Table 82. Inovio Pharmaceuticals Latest Developments
Table 83. Endo International Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 84. Endo International Needle-free Drug Injectors Product Portfolios and Specifications
Table 85. Endo International Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Endo International Main Business
Table 87. Endo International Latest Developments
Table 88. Injex Pharma GmbH Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 89. Injex Pharma GmbH Needle-free Drug Injectors Product Portfolios and Specifications
Table 90. Injex Pharma GmbH Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Injex Pharma GmbH Main Business
Table 92. Injex Pharma GmbH Latest Developments
Table 93. National Medical Products (J-Tip) Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 94. National Medical Products (J-Tip) Needle-free Drug Injectors Product Portfolios and Specifications
Table 95. National Medical Products (J-Tip) Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. National Medical Products (J-Tip) Main Business
Table 97. National Medical Products (J-Tip) Latest Developments
Table 98. Recipharm Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 99. Recipharm Needle-free Drug Injectors Product Portfolios and Specifications
Table 100. Recipharm Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Recipharm Main Business
Table 102. Recipharm Latest Developments
Table 103. InsuJet Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 104. InsuJet Needle-free Drug Injectors Product Portfolios and Specifications
Table 105. InsuJet Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. InsuJet Main Business
Table 107. InsuJet Latest Developments
Table 108. Miracle Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 109. Miracle Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 110. Miracle Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Miracle Medical Main Business
Table 112. Miracle Medical Latest Developments
Table 113. Medical International Technology (MIT) Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 114. Medical International Technology (MIT) Needle-free Drug Injectors Product Portfolios and Specifications
Table 115. Medical International Technology (MIT) Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Medical International Technology (MIT) Main Business
Table 117. Medical International Technology (MIT) Latest Developments
Table 118. Akra Dermojet Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 119. Akra Dermojet Needle-free Drug Injectors Product Portfolios and Specifications
Table 120. Akra Dermojet Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Akra Dermojet Main Business
Table 122. Akra Dermojet Latest Developments
Table 123. PharmaJet Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 124. PharmaJet Needle-free Drug Injectors Product Portfolios and Specifications
Table 125. PharmaJet Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. PharmaJet Main Business
Table 127. PharmaJet Latest Developments
Table 128. Portal Instruments Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 129. Portal Instruments Needle-free Drug Injectors Product Portfolios and Specifications
Table 130. Portal Instruments Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Portal Instruments Main Business
Table 132. Portal Instruments Latest Developments
Table 133. Crossject Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 134. Crossject Needle-free Drug Injectors Product Portfolios and Specifications
Table 135. Crossject Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Crossject Main Business
Table 137. Crossject Latest Developments
Table 138. Mika Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 139. Mika Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 140. Mika Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Mika Medical Main Business
Table 142. Mika Medical Latest Developments
Table 143. Ferring Pharmaceuticals Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 144. Ferring Pharmaceuticals Needle-free Drug Injectors Product Portfolios and Specifications
Table 145. Ferring Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Ferring Pharmaceuticals Main Business
Table 147. Ferring Pharmaceuticals Latest Developments
Table 148. IntegriMedical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 149. IntegriMedical Needle-free Drug Injectors Product Portfolios and Specifications
Table 150. IntegriMedical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. IntegriMedical Main Business
Table 152. IntegriMedical Latest Developments
Table 153. Helcomin Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 154. Helcomin Needle-free Drug Injectors Product Portfolios and Specifications
Table 155. Helcomin Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Helcomin Main Business
Table 157. Helcomin Latest Developments
Table 158. Nugen Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 159. Nugen Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 160. Nugen Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Nugen Medical Main Business
Table 162. Nugen Medical Latest Developments
Table 163. Lepu Medical Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 164. Lepu Medical Needle-free Drug Injectors Product Portfolios and Specifications
Table 165. Lepu Medical Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Lepu Medical Main Business
Table 167. Lepu Medical Latest Developments
Table 168. Beijing Quinovare Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 169. Beijing Quinovare Needle-free Drug Injectors Product Portfolios and Specifications
Table 170. Beijing Quinovare Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Beijing Quinovare Main Business
Table 172. Beijing Quinovare Latest Developments
Table 173. Qingdao Zhonghui Health Industrial Group Basic Information, Needle-free Drug Injectors Manufacturing Base, Sales Area and Its Competitors
Table 174. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product Portfolios and Specifications
Table 175. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Qingdao Zhonghui Health Industrial Group Main Business
Table 177. Qingdao Zhonghui Health Industrial Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Needle-free Drug Injectors
Figure 2. Needle-free Drug Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Needle-free Drug Injectors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Needle-free Drug Injectors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Needle-free Drug Injectors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Needle-free Drug Injectors Sales Market Share by Country/Region (2025)
Figure 10. Needle-free Drug Injectors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder Injections
Figure 12. Product Picture of Liquid Injections
Figure 13. Product Picture of Depot or Projectile Injection
Figure 14. Global Needle-free Drug Injectors Sales Market Share by Type in 2026
Figure 15. Global Needle-free Drug Injectors Revenue Market Share by Type (2021-2026)
Figure 16. Needle-free Drug Injectors Consumed in Vaccine Delivery
Figure 17. Global Needle-free Drug Injectors Market: Vaccine Delivery (2021-2026) & (K Units)
Figure 18. Needle-free Drug Injectors Consumed in Insulin Delivery
Figure 19. Global Needle-free Drug Injectors Market: Insulin Delivery (2021-2026) & (K Units)
Figure 20. Needle-free Drug Injectors Consumed in Others
Figure 21. Global Needle-free Drug Injectors Market: Others (2021-2026) & (K Units)
Figure 22. Global Needle-free Drug Injectors Sale Market Share by Application (2025)
Figure 23. Global Needle-free Drug Injectors Revenue Market Share by Application in 2026
Figure 24. Needle-free Drug Injectors Sales by Company in 2026 (K Units)
Figure 25. Global Needle-free Drug Injectors Sales Market Share by Company in 2026
Figure 26. Needle-free Drug Injectors Revenue by Company in 2026 ($ millions)
Figure 27. Global Needle-free Drug Injectors Revenue Market Share by Company in 2026
Figure 28. Global Needle-free Drug Injectors Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Needle-free Drug Injectors Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 31. Americas Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 32. APAC Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 33. APAC Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 34. Europe Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 35. Europe Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 38. Americas Needle-free Drug Injectors Sales Market Share by Country in 2026
Figure 39. Americas Needle-free Drug Injectors Revenue Market Share by Country (2021-2026)
Figure 40. Americas Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 41. Americas Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 42. United States Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Needle-free Drug Injectors Sales Market Share by Region in 2026
Figure 47. APAC Needle-free Drug Injectors Revenue Market Share by Region (2021-2026)
Figure 48. APAC Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 49. APAC Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 50. China Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 54. India Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Needle-free Drug Injectors Sales Market Share by Country in 2026
Figure 58. Europe Needle-free Drug Injectors Revenue Market Share by Country (2021-2026)
Figure 59. Europe Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 60. Europe Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 61. Germany Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 62. France Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Needle-free Drug Injectors Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 69. Egypt Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Needle-free Drug Injectors in 2026
Figure 75. Manufacturing Process Analysis of Needle-free Drug Injectors
Figure 76. Industry Chain Structure of Needle-free Drug Injectors
Figure 77. Channels of Distribution
Figure 78. Global Needle-free Drug Injectors Sales Market Forecast by Region (2027-2032)
Figure 79. Global Needle-free Drug Injectors Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Needle-free Drug Injectors Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Needle-free Drug Injectors Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Needle-free Drug Injectors Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Needle-free Drug Injectors Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Needle-free Drug Injectors
Figure 2. Needle-free Drug Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Needle-free Drug Injectors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Needle-free Drug Injectors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Needle-free Drug Injectors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Needle-free Drug Injectors Sales Market Share by Country/Region (2025)
Figure 10. Needle-free Drug Injectors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder Injections
Figure 12. Product Picture of Liquid Injections
Figure 13. Product Picture of Depot or Projectile Injection
Figure 14. Global Needle-free Drug Injectors Sales Market Share by Type in 2026
Figure 15. Global Needle-free Drug Injectors Revenue Market Share by Type (2021-2026)
Figure 16. Needle-free Drug Injectors Consumed in Vaccine Delivery
Figure 17. Global Needle-free Drug Injectors Market: Vaccine Delivery (2021-2026) & (K Units)
Figure 18. Needle-free Drug Injectors Consumed in Insulin Delivery
Figure 19. Global Needle-free Drug Injectors Market: Insulin Delivery (2021-2026) & (K Units)
Figure 20. Needle-free Drug Injectors Consumed in Others
Figure 21. Global Needle-free Drug Injectors Market: Others (2021-2026) & (K Units)
Figure 22. Global Needle-free Drug Injectors Sale Market Share by Application (2025)
Figure 23. Global Needle-free Drug Injectors Revenue Market Share by Application in 2026
Figure 24. Needle-free Drug Injectors Sales by Company in 2026 (K Units)
Figure 25. Global Needle-free Drug Injectors Sales Market Share by Company in 2026
Figure 26. Needle-free Drug Injectors Revenue by Company in 2026 ($ millions)
Figure 27. Global Needle-free Drug Injectors Revenue Market Share by Company in 2026
Figure 28. Global Needle-free Drug Injectors Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Needle-free Drug Injectors Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 31. Americas Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 32. APAC Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 33. APAC Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 34. Europe Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 35. Europe Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Needle-free Drug Injectors Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Needle-free Drug Injectors Revenue 2021-2026 ($ millions)
Figure 38. Americas Needle-free Drug Injectors Sales Market Share by Country in 2026
Figure 39. Americas Needle-free Drug Injectors Revenue Market Share by Country (2021-2026)
Figure 40. Americas Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 41. Americas Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 42. United States Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Needle-free Drug Injectors Sales Market Share by Region in 2026
Figure 47. APAC Needle-free Drug Injectors Revenue Market Share by Region (2021-2026)
Figure 48. APAC Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 49. APAC Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 50. China Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 54. India Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Needle-free Drug Injectors Sales Market Share by Country in 2026
Figure 58. Europe Needle-free Drug Injectors Revenue Market Share by Country (2021-2026)
Figure 59. Europe Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 60. Europe Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 61. Germany Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 62. France Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Needle-free Drug Injectors Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Needle-free Drug Injectors Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Needle-free Drug Injectors Sales Market Share by Application (2021-2026)
Figure 69. Egypt Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Needle-free Drug Injectors Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Needle-free Drug Injectors in 2026
Figure 75. Manufacturing Process Analysis of Needle-free Drug Injectors
Figure 76. Industry Chain Structure of Needle-free Drug Injectors
Figure 77. Channels of Distribution
Figure 78. Global Needle-free Drug Injectors Sales Market Forecast by Region (2027-2032)
Figure 79. Global Needle-free Drug Injectors Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Needle-free Drug Injectors Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Needle-free Drug Injectors Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Needle-free Drug Injectors Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Needle-free Drug Injectors Revenue Market Share Forecast by Application (2027-2032)
